Zolpidem Tartrate



Indications and Reactions:

Role Indications Reactions
Primary
Drug Use For Unknown Indication 34.2%
Insomnia 24.0%
Product Used For Unknown Indication 18.4%
Sleep Disorder 6.0%
Depression 4.7%
Hypertension 2.1%
Pain 1.9%
Anxiety 1.6%
Dementia Alzheimer's Type 1.1%
Suicide Attempt 0.9%
Intentional Overdose 0.8%
Drug Abuse 0.6%
Drug Dependence 0.6%
Osteoporosis 0.5%
Prophylaxis 0.5%
Completed Suicide 0.5%
Atrial Fibrillation 0.4%
Diabetes Mellitus 0.4%
Nasopharyngitis 0.4%
Back Pain 0.4%
Completed Suicide 15.5%
Somnambulism 15.3%
Drug Ineffective 10.1%
Insomnia 7.0%
Cardio-respiratory Arrest 5.4%
Road Traffic Accident 5.4%
Delirium 4.6%
Product Substitution Issue 4.2%
Therapeutic Response Unexpected With Drug Substitution 4.2%
Maternal Exposure During Pregnancy 3.4%
Death 3.2%
Somnolence 3.2%
Tremor 3.0%
Vomiting 3.0%
Overdose 2.4%
Loss Of Consciousness 2.0%
Rhabdomyolysis 2.0%
Sleep-related Eating Disorder 2.0%
Unresponsive To Stimuli 2.0%
Drug Abuse 1.8%
Secondary
Drug Use For Unknown Indication 24.7%
Product Used For Unknown Indication 23.9%
Insomnia 10.0%
Depression 9.8%
Anxiety 5.0%
Sleep Disorder 3.3%
Dementia Alzheimer's Type 3.0%
Self Injurious Behaviour 2.9%
Feeling Abnormal 2.8%
Frustration 2.8%
Hypertension 2.1%
Pain 2.0%
Back Pain 1.5%
Alcoholism 1.0%
Prophylaxis 1.0%
Ill-defined Disorder 0.9%
Asthma 0.8%
Completed Suicide 0.8%
Foetal Exposure During Pregnancy 0.8%
Bipolar Disorder 0.8%
Completed Suicide 22.8%
Somnolence 8.9%
Death 7.9%
Suicide Attempt 6.2%
Vomiting 5.8%
Cardio-respiratory Arrest 5.2%
Overdose 5.2%
Respiratory Arrest 4.8%
Toxicity To Various Agents 4.6%
Unresponsive To Stimuli 4.4%
Somnambulism 3.8%
Weight Increased 3.2%
Tachycardia 2.4%
Weight Decreased 2.4%
Delirium 2.2%
Drug Toxicity 2.2%
Intentional Overdose 2.2%
Road Traffic Accident 2.2%
Drug Abuse 2.0%
Fall 2.0%
Concomitant
Drug Use For Unknown Indication 27.0%
Product Used For Unknown Indication 22.0%
Insomnia 7.1%
Rheumatoid Arthritis 7.0%
Depression 5.0%
Hypertension 4.7%
Prophylaxis 4.3%
Pain 4.3%
Hiv Infection 2.9%
Anxiety 2.0%
Diabetes Mellitus 1.8%
Sleep Disorder 1.7%
Crohn's Disease 1.7%
Osteoporosis 1.6%
Multiple Myeloma 1.4%
Constipation 1.3%
Gastrooesophageal Reflux Disease 1.2%
Non-small Cell Lung Cancer 1.1%
Schizophrenia 1.0%
Hepatitis C 0.8%
Vomiting 15.1%
Weight Decreased 7.8%
White Blood Cell Count Decreased 7.6%
Pyrexia 7.4%
Pneumonia 5.9%
Weight Increased 5.4%
Thrombocytopenia 5.1%
Rash 5.0%
Somnolence 4.8%
Pain 3.9%
Pneumothorax 3.8%
Nausea 3.5%
Renal Failure Acute 3.5%
Suicide Attempt 3.3%
Tachycardia 3.3%
White Blood Cell Count Increased 3.3%
Renal Failure 3.2%
Sepsis 2.8%
Pulmonary Embolism 2.7%
Vision Blurred 2.6%
Interacting
Product Used For Unknown Indication 22.6%
Drug Use For Unknown Indication 11.9%
Insomnia 11.9%
Emotional Distress 9.5%
Major Depressive Disorder Nos 7.1%
Pain 7.1%
Anxiety 4.2%
Depression 3.6%
Sleep Disorder 3.6%
Hypertension 3.0%
Type 2 Diabetes Mellitus 3.0%
Prophylaxis Against Gastrointestinal Ulcer 2.4%
Dysthymic Disorder 1.8%
Antibiotic Therapy 1.2%
Benign Prostatic Hyperplasia 1.2%
Chronic Obstructive Pulmonary Disease 1.2%
Constipation 1.2%
Dementia Of The Alzheimer's Type, With Depressed Mood 1.2%
Hiv Infection 1.2%
Ischaemic Heart Disease Prophylaxis 1.2%
Fall 10.3%
Rhabdomyolysis 10.3%
Drug Interaction 6.9%
Drug Toxicity 6.9%
Homicide 6.9%
Speech Disorder 6.9%
Thinking Abnormal 6.9%
Dementia 3.4%
Dizziness 3.4%
Drug Level Increased 3.4%
Gait Disturbance 3.4%
Hallucination 3.4%
Hypercapnia 3.4%
Hyperkalaemia 3.4%
Loss Of Consciousness 3.4%
Oxygen Saturation Decreased 3.4%
Pain 3.4%
Paranoia 3.4%
Pyrexia 3.4%
Respiratory Depression 3.4%